STYRYLACRYLONITRILE COMPOUNDS FOR INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR - Patent 1551381

(19)

(11)

EP 1 551 381 A2

(12)

(88)	Date of publication A3:
	17.06.2004

(43)	Date of publication:
	13.07.2005 Bulletin 2005/28

(21)	Application number: 03757609.7

(22)	Date of filing: 10.10.2003

(51)	International Patent Classification (IPC)⁷: A61K 31/165, A61K 31/216, A61K 31/137, A61K 31/277, A61K 31/662, A61P 35/00, A61P 35/02, A61P 37/06, A61P 31/22, A61P 27/02, A61P 19/08, A61P 17/00

(86)	International application number:
	PCT/CA2003/001558

(87)	International publication number:
	WO 2004/032911 (22.04.2004 Gazette 2004/17)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

11.10.2002 US 417642 P
11.10.2002 CA 2407755

(71)	Applicant: The Hospital for Sick Children
	Toronto,Ontario M5G 1X8 (CA)

(72)	Inventors:
	Roifman, Chaim M. North York,Ontario M2R 1A4 (CA) Simon, Amos J. 56452 Yehud (IL) Demini Peter M. Toronto,Ontario M6P 2S1 (CA) Rounova, Olga B. Toronto,Ontario M6P 2S1 (CA)

(74)	Representative: VOSSIUS & PARTNER
	Siebertstrasse 4 81675 München 81675 München (DE)

(54)	STYRYLACRYLONITRILE COMPOUNDS FOR INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR